The initiation of coverage by B of A Securities with a Neutral rating and a specific price target provides investors with a new analytical perspective on Merit Medical Systems. However, the Neutral rating suggests that the analyst sees the stock as fairly valued at its current price, implying limited short-term price movement. The price target of $87 offers a reference point for future performance expectations but does not strongly suggest significant upside or downside, hence the neutral impact score.